Hagan currently serves as Chief Commercial Officer at ModifyHealth. With over 15 years in the GI/Endoscopy space, Hagan has a history of commercializing innovative products and services that have dramatic impact on patient care. Prior to ModifyHealth, Hagan served as Senior Director of Marketing at EndoChoice and Marketing Channel Manager for the GI ASC Division at Boston Scientific.
Hagan serves as Chief Commercial Officer at ModifyHealth and has a history of commercializing innovative products and services that have dramatic impact on patient care.
Prior to ModifyHealth, Hagan helped launch EndoChoice, a developer of innovative healthcare products and services for the GI space. While at EndoChoice, Hagan served in multiple sales and marketing leadership roles including Global Marketing Leader for Imaging & Technology Enabled Services as as well as Senior Director of Marketing. EndoChoice grew from a startup in 2008 to public offering in 2015 (NYSE: GI) and final sale to Boston Scientific in 2016 (NYSE: BSX).
During Hagan’s time at Boston Scientific, he served in multiple roles including Group Manager of Pathology and Marketing Channel Manager for the GI Ambulatory Surgery Center Division.
